ArticleFrontiers in medicine2026

Case Report: Bevacizumab combined with chemotherapy followed by PARP inhibitor maintenance therapy in

Donghai Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.